Double-blind, Randomized, Placebo-controlled Two-period Crossover Study to Assess the Effect of Levocarnitine on Vismodegib-associated Muscle Spasms

This randomized clinical trial studies levocarnitine in treating patients with vismodegib-associated muscle spasms. Levocarnitine may decrease muscle spasms caused by vismodegib.

Stanford is now accepting new patients for this trial. Please contact Anne Lynn Chang at 650-721-7151 for more information.

Investigator(s):

Intervention(s):

  • dietary supplement : levocarnitine
  • other : questionnaire administration
  • other : placebo

Phase: N/A

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

- Taking vismodegib daily - Subject answers item #1 of muscle spasms questionnaire as moderate or severe intensity at time of screening - At least one muscle spasm per day at time of screening - Muscle spasms onset after starting vismodegib - Willing and able to understand and sign consent form

External Links

Explore related trials

Contact information

Primary Contact:

Anne Lynn Chang 650-721-7151

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: